Photo of the the Narberth Cystic Fibrosis Run The Narberth Cystic Fibrosis Run will…
Charles Moore
Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Charles Moore
Arkansas Medicaid has settled a federal lawsuit brought by three cystic fibrosis (CF) patients who were denied the CF…
A team of scientists of The University of Bath’s Department of Biology & Biochemistry in Bath, U.K. report that…
“Laser Trapping” Technique Could Lead To Better Management of Bacterial Infections in CF Patients
In a report published this week by SPIE — an international not-for-profit society serving more than 256,000 constituents from…
Two recently published reviews in peer-reviewed journals plus another study highlight the potential utility of ceragenins or cationic selective…
Nottingham University Hospital NHS Trust in the U.K. has announced a new state of the art facility utilizing technology…
The Cystic Fibrosis Foundation (CFF) announced this week that its nonprofit affiliate, Cystic Fibrosis Foundation Therapeutics, has…
Santa Fe, New Mexico based startup Avisa Pharma Inc. is a clinical stage company established in 2010 to develop…
An Optical Society release notes that while people might typically regard mucus as an “icky bodily secretion best left wrapped in…
Vertex Pharmaceuticals Incorporated announced Tuesday that the U.S. Food and Drug Administration’s Pulmonary Allergy Drugs Advisory Committee (PADAC) voted…